Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 134

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Comprehensive Review of Current and Upcoming Anti-Obesity Drugs

Son, Jang Won, Kim, Sungrae·2020·Diabetes & Metabolism Journal

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4093/dmj.2020.0258

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 42

  1. 10.1016/s0140-6736(05)67483-1 · DOI · Paper page
  2. 10.2337/db08-0210 · DOI · Paper page
  3. 2000, WHO Consultation on Obesity
  4. 10.1016/S0140-6736(18)32822-8 · DOI · Paper page
  5. 10.1038/nrendo.2017.122 · DOI · Paper page
  6. 10.2165/00003495-199958040-00015 · DOI
  7. 10.1592/phco.20.4.270.34882 · DOI · Paper page
  8. Drew, 2007, Obesity management: update on orlistat, 817
  9. 10.2337/diacare.27.1.155 · DOI · Paper page
  10. 10.1136/bmj.39406.519132.ad · DOI
  11. 10.1016/s0014-2999(02)01422-x · DOI · Paper page
  12. 10.1001/jama.293.23.2873 · DOI · Paper page
  13. 10.2147/dddt.s55587 · DOI · Paper page
  14. 10.1038/nature14260 · DOI · Paper page
  15. Dutia, 2012, β-Endorphin antagonizes the effects of α-MSH on food intake and body weight, 4246
  16. 10.1007/s40265-015-0427-5 · DOI
  17. 10.1016/s0140-6736(10)60888-4 · DOI · Paper page
  18. Apovian, 2013, A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II), 935
  19. 10.1038/oby.2010.147 · DOI · Paper page
  20. 10.1007/978-3-642-24716-3_20 · DOI
  21. 10.1016/s0140-6736(11)60205-5 · DOI · Paper page
  22. 10.1038/oby.2011.330 · DOI · Paper page
  23. 10.1001/jama.2016.7602 · DOI · Paper page
  24. 10.1002/pds.3612 · DOI
  25. 10.1016/j.yend.2012.05.008 · doi:10.1016/j.yend.2012.05.008
  26. 10.1111/j.1467-789X.2011.00860.x · DOI
  27. 10.1038/nrendo.2011.77 · DOI · Paper page
  28. 10.1016/S0140-6736(17)30069-7 · DOI · Paper page
  29. 10.1016/S0140-6736(15)00803-X · DOI · Paper page
  30. 10.1016/j.rbmo.2017.03.023 · DOI · Paper page
  31. 10.1016/s2213-8587(19)30157-3 · DOI · Paper page
  32. 10.1056/nejmc1611289 · DOI · Paper page
  33. 10.2337/dc15-0772 · DOI · Paper page
  34. Wang, 2014, Effect of combined naltrexone and bupropion therapy on the brain’s reactivity to food cues, 682
  35. 10.4158/ep161356.esgl · DOI · Paper page
  36. 10.1038/clpt.2013.204 · DOI · Paper page
  37. 10.1007/s00018-014-1650-z · DOI
  38. 10.1038/s41591-018-0015-9 · DOI · Paper page
  39. Haws, 2020, Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome, 2133
  40. 10.1016/s0140-6736(08)61525-1 · DOI · Paper page
  41. 10.1038/ijo.2010.87 · DOI
  42. 10.1007/s00592-017-0994-x · DOI

Cited by

See all 134

Metadata

Authors
Son, J. W., & Kim, S.
Venue
Diabetes & Metabolism Journal
Published
2020-12-31
Volume
44
Issue
6
Pages
802-818
ISSN
  • 2233-6079
  • 2233-6087
Cited by
134
References
31
Language
en
Licence
creativecommons.org/licenses/by-nc/4.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comprehensive Review of Current and Upcoming Anti-Obesity Drugs. https://app.cochat.ai/papers/10.4093/dmj.2020.0258
The paper
Son, J. W., & Kim, S. (2020). Comprehensive Review of Current and Upcoming Anti-Obesity Drugs. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2020.0258

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.